» Authors » Aviv A Shaul

Aviv A Shaul

Explore the profile of Aviv A Shaul including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 139
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shaul A, Ben Avraham B, Itzhaki Ben Zadok O, Tovar A, Aravot D, Ben Gal T
Harefuah . 2024 Nov; 162(5):299-304. PMID: 39569964
Allograft rejection is a major challenge in the treatment of heart transplant recipients. The rejection is pathophysiological categorized into cellular rejection, mediated by lymphocytes and antibody-medicated rejection (AMR). We will...
2.
Hammer Y, Shaul A, Ben-Avraham B, Itzhaki Ben Zadok O, Barac Y, Rubchevsky V, et al.
ESC Heart Fail . 2022 Oct; 10(1):738-741. PMID: 36251532
Aims: Exercise games (exergames) have been recently proposed as a mode of facilitating physical activity in patients with chronic diseases. Although patients supported with left ventricular assist devices (LVADs) benefit...
3.
Shaked E, Shaul A, Perl L, Leshem-Lev D, Sevilya Z, Kheifets M, et al.
Coron Artery Dis . 2022 Jul; 33(7):540-546. PMID: 35866511
Background: Endothelial progenitor cells (EPCs) have an important role in repair following vascular injury. Telomere length has been shown to be correlated with genome stability and overall cell health. We...
4.
Abu Akel M, Shaul A, Goldenberg G, Barac Y, Ben-Avraham B, Gorfil D, et al.
ESC Heart Fail . 2022 Jun; 9(5):3593-3596. PMID: 35715959
Ventricular fibrillation, a life-threatening ventricular arrhythmia, may result in pulselessness, loss of consciousness and sudden cardiac death. In this case report, we describe our experience in managing a 54-year-old man...
5.
Talmor-Barkan Y, Bar N, Shaul A, Shahaf N, Godneva A, Bussi Y, et al.
Nat Med . 2022 Feb; 28(2):295-302. PMID: 35177859
Complex diseases, such as coronary artery disease (CAD), are often multifactorial, caused by multiple underlying pathological mechanisms. Here, to study the multifactorial nature of CAD, we performed comprehensive clinical and...
6.
Itzhaki Ben Zadok O, Shaul A, Ben-Avraham B, Yaari V, Ben Zvi H, Eliakim-Raz N, et al.
ESC Heart Fail . 2022 Jan; 9(2):905-911. PMID: 34981657
Aims: To assess the 6 months immunogenicity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine in a population of heart transplanted (HTx) recipients and left ventricular assist device...
7.
Itzhaki Ben Zadok O, Shaul A, Ben-Avraham B, Yaari V, Ben Zvi H, Shostak Y, et al.
Eur J Heart Fail . 2021 May; 23(9):1555-1559. PMID: 33963635
Aims: To assess the short-term immunogenicity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine in a population of heart transplant (HTx) recipients. A prospective single-centre cohort study of...
8.
Levi A, Landes U, Assali A, Orvin K, Sharony R, Vaknin-Assa H, et al.
Am J Cardiol . 2017 Apr; 119(11):1821-1831. PMID: 28388992
Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis in patients at high or prohibitive surgical risk. Nevertheless, long-term clinical and echocardiographic data are still lacking....
9.
10.
Witberg G, Barsheshet A, Assali A, Vaknin-Assa H, Shaul A, Orvin K, et al.
Cardiology . 2016 Mar; 134(2):128-35. PMID: 26953820
Objectives: To explore the relation between the baseline aortic valve gradient (AVG) as a continuous variable and clinical outcomes following transcatheter aortic valve implantation (TAVI) in general and specifically in...